Morgan Stanley’s OnKure Therapeutics, Inc. Class A Common Stock OKUR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.9K | Buy |
16,701
+14,823
| +789% | +$35.4K | ﹤0.01% | 6428 |
|
|
2025
Q1 | $8.08K | Buy |
1,878
+946
| +102% | +$4.07K | ﹤0.01% | 6866 |
|
|
2024
Q4 | $8.02K | Sell |
932
-5,520
| -86% | -$47.5K | ﹤0.01% | 6877 |
|
|
2024
Q3 | $110K | Sell |
6,452
-13,400
| -67% | -$228K | ﹤0.01% | 5972 |
|
|
2024
Q2 | $300K | Sell |
19,852
-2,864
| -13% | -$43.2K | ﹤0.01% | 5503 |
|
|
2024
Q1 | $377K | Sell |
22,716
-2,269
| -9% | -$37.7K | ﹤0.01% | 5435 |
|
|
2023
Q4 | $400K | Buy |
24,985
+21,753
| +673% | +$348K | ﹤0.01% | 5703 |
|
|
2023
Q3 | $246K | Sell |
3,232
-344
| -10% | -$26.2K | ﹤0.01% | 5493 |
|
|
2023
Q2 | $235K | Sell |
3,576
-657
| -16% | -$43.1K | ﹤0.01% | 5579 |
|
|
2023
Q1 | $253K | Buy |
4,233
+276
| +7% | +$16.5K | ﹤0.01% | 5598 |
|
|
2022
Q4 | $92.2K | Sell |
3,957
-32
| -0.8% | -$746 | ﹤0.01% | 6012 |
|
|
2022
Q3 | $134K | Buy |
3,989
+1,939
| +95% | +$65.1K | ﹤0.01% | 5928 |
|
|
2022
Q2 | $54K | Buy |
2,050
+1,509
| +279% | +$39.7K | ﹤0.01% | 6575 |
|
|
2022
Q1 | $16K | Sell |
541
-174
| -24% | -$5.15K | ﹤0.01% | 7242 |
|
|
2021
Q4 | $61K | Buy |
715
+299
| +72% | +$25.5K | ﹤0.01% | 6721 |
|
|
2021
Q3 | $30K | Sell |
416
-2,703
| -87% | -$195K | ﹤0.01% | 6930 |
|
|
2021
Q2 | $291K | Buy |
+3,119
| New | +$291K | ﹤0.01% | 5831 |
|